利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

14 条记录 (耗时 0.037 秒)

    Plasma speaker
    1.
    发明授权
    Plasma speaker 有权

    公开(公告)号：US10567887B2

    公开(公告)日：2020-02-18

    申请号：US16304594

    申请日：2017-06-21

    申请人： Paul Gilligan

    发明人： Paul Gilligan

    IPC分类号： H04R23/00 ,  H04R1/30 ,  B03C3/38

    摘要： A speaker (10) comprises an enclosure (8) defining an internal volume (11); and at least one sound generator (7), the sound generator (7) comprising one or more surfaces defining an air-path conduit (15) through which air operably passes in and out of the internal volume. The sound generator (7) further comprises a plurality of electrodes comprising at least one air-exposed electrode (1, 4) and at least one insulated electrode (2, 3). A voltage source (6) is configured to generate an electrical field between the at least one air-exposed electrode (1, 4) and the at least one insulated electrode (2, 3, 70) to operatively generate a plasma proximal (100) to the plurality of electrodes and within the air-path conduit (15).

    Sulfonamide bicyclic compounds
    3.
    发明申请
    Sulfonamide bicyclic compounds 有权
    磺酰胺双环化合物

    公开(公告)号：US20060063799A1

    公开(公告)日：2006-03-23

    申请号：US11231410

    申请日：2005-09-21

    申请人： Paul Gilligan

    发明人： Paul Gilligan

    IPC分类号： A61K31/4709 ,  A61K31/4704 ,  C07D409/02

    CPC分类号： C07D209/08 ,  C07D215/227 ,  C07D217/24 ,  C07D401/06

    摘要： The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts and solvates, their pharmaceutical compositions, and their uses in inhibiting β-amyloid peptide (β-AP) production.

    摘要翻译： 本发明包括式I的化合物，包括其药学上可接受的盐和溶剂合物，其药物组合物及其在抑制β-淀粉样蛋白肽（β-AP）生产中的用途。

    Tetrazine bicyclic compounds
    4.
    发明授权
    Tetrazine bicyclic compounds 失效
    四嗪双环化合物

    公开(公告)号：US06313124B1

    公开(公告)日：2001-11-06

    申请号：US09014734

    申请日：1998-01-28

    申请人： Liqi He ,  Paul Gilligan ,  Robert Chorvat ,  Argyrios Georgios Arvanitis

    发明人： Liqi He ,  Paul Gilligan ,  Robert Chorvat ,  Argyrios Georgios Arvanitis

    IPC分类号： A61K31535

    CPC分类号： A61K31/53 ,  C07D487/04

    摘要： Corticotropin releasing factor (CRF) antagonists of formula I or II: and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.

    摘要翻译： 式I或II的促肾上腺皮质激素释放因子（CRF）拮抗剂及其用于治疗焦虑，抑郁和其他精神疾病，神经障碍以及治疗与精神病理学障碍和应激相关的免疫学，心血管或心脏相关疾病和结肠超敏反应的用途 。

    Azolo triazines and pyrimidines
    5.
    发明授权
    Azolo triazines and pyrimidines 失效
    偶氮三嗪和嘧啶

    公开(公告)号：US06191131B1

    公开(公告)日：2001-02-20

    申请号：US09015002

    申请日：1998-01-28

    申请人： Liqi He ,  Paul Gilligan ,  Robert Chorvat ,  Argyrios Georgios Arvanitis

    发明人： Liqi He ,  Paul Gilligan ,  Robert Chorvat ,  Argyrios Georgios Arvanitis

    IPC分类号： C07D48704

    CPC分类号： C07D487/04

    摘要： Corticotropin releasing factor (CRF) antagonists of formula I or II: and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.

    摘要翻译： 式I或II的促肾上腺皮质激素释放因子（CRF）拮抗剂及其用于治疗焦虑，抑郁和其他精神疾病，神经障碍以及治疗与精神病理学障碍和应激相关的免疫学，心血管或心脏相关疾病和结肠超敏反应的用途 。

    Azolo triazines and pyrimidines
    6.
    发明授权
    Azolo triazines and pyrimidines 失效
    偶氮三嗪和嘧啶

    公开(公告)号：US6060478A

    公开(公告)日：2000-05-09

    申请号：US15001

    申请日：1998-01-28

    申请人： Paul Gilligan ,  Robert Chorvat ,  Argyrios Georgios Arvanitis

    发明人： Paul Gilligan ,  Robert Chorvat ,  Argyrios Georgios Arvanitis

    IPC分类号： C07D487/04 ,  A61K31/505

    CPC分类号： C07D487/04

    摘要： Corticotropin releasing factor (CRF) antagonists of formula I or II: ##STR1## and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.

    摘要翻译： 式I或II的促肾上腺皮质激素释放因子（CRF）拮抗剂及其用于治疗焦虑，抑郁和其他精神疾病，神经障碍以及治疗与精神病理学障碍和应激相关的免疫学，心血管或心脏相关疾病和结肠超敏反应的用途 。

    PLASMA SPEAKER
    7.
    发明申请
    PLASMA SPEAKER 审中-公开

    公开(公告)号：US20190215616A1

    公开(公告)日：2019-07-11

    申请号：US16304594

    申请日：2017-06-21

    申请人： Paul Gilligan

    发明人： Paul Gilligan

    IPC分类号： H04R23/00 ,  H04R1/30 ,  B03C3/38

    摘要： A speaker (10) comprises an enclosure (8) defining an internal volume (11); and at least one sound generator (7), the sound generator (7) comprising one or more surfaces defining an air-path conduit (15) through which air operably passes in and out of the internal volume. The sound generator (7) further comprises a plurality of electrodes comprising at least one air-exposed electrode (1, 4) and at least one insulated electrode (2, 3). A voltage source (6) is configured to generate an electrical field between the at least one air-exposed electrode (1, 4) and the at least one insulated electrode (2, 3, 70) to operatively generate a plasma proximal (100) to the plurality of electrodes and within the air-path conduit (15).